Human VEGF-C ELISA Kit PicoKine(r)

Name: Human VEGF-C ELISA Kit PicoKine(r)
SKU: EK0588_1x96wellplate_B70
Availability: BackOrder

EK0588

ReactivityHuman

Product group Assays

Overview

Supplier
Boster Bio
Product Name
Human VEGF-C PicoKine ELISA Kit
Delivery Days Customer
9
Applications
ELISA
Applications Supplier
ELI
Assay Detection Range
62.5 pg/ml - 4,000 pg/ml
Assay Sensitivity
<3 pg/ml
Assay Specificity
Natural human VEGF-C, recombinant human VEGF-C (wild type), and recombinant human VEGF-C (Cys156Ser substituted)
Assay Time
15-20
Certification
Research Use Only
Scientific Description
Human VEGF-C ELISA Kit PicoKine® (96 Tests). Quantitate Human VEGFC in cell culture supernatants, cell lysates, serum and plasma (heparin, EDTA). Sensitivity: 3pg/ml. The brand Picokine indicates this is a premium quality ELISA kit. Each Picokine kit delivers precise quantification, high sensitivity, and excellent reproducibility. Only our most reliable and effective kits qualify as Picokine, guaranteeing top-tier results for your assays.
Reactivity
Human
Reactivity Supplier
Human VEGF-C
Storage Instruction
-20°C,2°C to 8°C
UNSPSC
41116158

Angiotensin II Induces Cardiac Edema and Hypertrophic Remodeling through Lymphatic-Dependent Mechanisms. Bai J et al., 2022, Oxid Med Cell Longev
Read more
Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4- NF-kappaB/JNK pathways in colorectal cancer.
Read more
SARI inhibits angiogenesis and tumour growth of human colon cancer through directly targeting ceruloplasmin.
Read more
IL-6 mediates the signal pathway of JAK-STAT3-VEGF-C promoting growth, invasion and lymphangiogenesis in gastric cancer.
Read more
High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma. Xu YF et al., 2015 Mar 21, World J Gastroenterol
Read more
Nuclear factor of activated T cells 5 maintained by Hotair suppression of miR-568 upregulates S100 calcium binding protein A4 to promote breast cancer metastasis.
Read more
CYR61 modulates the vascular endothelial growth factor C expression of decidual NK cells via PI3K/AKT pathway.
Read more
High-density lipoprotein of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells.
Read more
RNA interference (RNAi)-mediated vascular endothelial growth factor-C (VEGF-C) reduction interferes with lymphangiogenesis and enhances epirubicin sensitivity of breast cancer cells.
Read more